Dihydromyricetin suppresses cell metastasis in human osteosarcoma through SP-1- and NF-κB-modulated urokinase plasminogen activator inhibition

Publication date: Available online 26 June 2021Source: PhytomedicineAuthor(s): Chia-Hsuan Chou, Ko-Hsiu Lu, Jia-Sin Yang, Yi-Hsien Hsieh, Chiao-Wen Lin, Shun-Fa Yang
Source: Phytomedicine - Category: Drugs & Pharmacology Source Type: research